Navigation Links
Lung Cancer Scares Vary by State, Study Finds
Date:4/9/2013

TUESDAY, April 9 (HealthDay News) -- The percentage of patients found to have harmless lung disease after undergoing surgery for suspected lung cancer varies widely by state, a new study finds.

This discrepancy could affect the success of a national lung cancer screening program, the researchers noted.

Researchers analyzed data from more than 25,000 U.S. patients in the National Lung Screening Trial who underwent surgery for known or suspected lung cancer in 2009. Overall, 9.1 percent of the patients were found to have benign lung disease.

However, the rates of patients with benign lung disease varied widely, ranging from 1.2 percent in Vermont to 25 percent in Hawaii, according to the study, scheduled for presentation Tuesday at the American Association for Cancer Research annual meeting in Washington, D.C.

The study also found that about 2.3 percent of all patients died in the hospital after undergoing surgery, including 2.1 percent of those found not to have lung cancer.

The researchers noted that the National Lung Cancer Screening Trial showed that low-dose CT screening led to a 20 percent reduction in lung cancer-related deaths, compared with chest X-ray.

"Given the results of the National Lung Screening Trial [NLST], which demonstrated that low-dose computed tomography [CT] reduces lung cancer mortality, and the support for screening healthy, high-risk individuals with low-dose CT by clinical and patient advocacy groups, we will likely see screening for lung cancer in our near future," study author Stephen Deppen, a doctoral candidate in epidemiology and database analyst at Vanderbilt University, said in an association news release.

However, a national lung cancer screening program may yield uneven results if there are wide variations among states in the numbers of patients found to have benign lung disease, according to the researchers.

The point of lung cancer screening is finding early-stage disease and treating it when it is curable. However, "lung surgery is major surgery and has a much higher risk for death and complications compared with diagnostic operations for other cancers, such as breast and prostate cancer," Deppen said. "So, more surgeries for benign disease will result in more deaths and harm from the diagnostic process and will reduce the benefit that was observed in the original NLST."

Data and conclusions presented at meetings typically are considered preliminary until published in a peer-reviewed medical journal.

More information

The American Lung Association has more about lung cancer.

-- Robert Preidt

SOURCE: American Association for Cancer Research, news release, April 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer Scares Vary by State, Study Finds
(Date:1/24/2017)... ... January 23, 2017 , ... ... statement on the imposition of the Mexico City Policy, also known as the ... again today through Executive action, prohibits foreign non-governmental organizations from receiving any U.S. ...
(Date:1/24/2017)... ... January 23, 2017 , ... Somnoware, a leading ... allows sleep centers to automatically connect and initialize all their devices with one ... plugin is quickly installed on first use and then monitors device changes automatically. ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... nonprofit educational institution’s inaugural K-20 Education Summit to be held March 23-25, 2017 ... present by Jan. 25, 2017. , The keynote speakers include Dr. Michelle R. ...
(Date:1/23/2017)... ... 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate and feared ... benefits of making new water infrastructure a number one priority. “As we usher in ... water infrastructure to become a top priority of our new political change agents.” Kleyne ...
(Date:1/23/2017)... ... January 23, 2017 , ... Steviva Ingredients, ... certification under the USDA National Organic Program (NOP) for its Portland SQF Level ... established organic production and handling systems to complement our current rigorous food-safety management ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , Jan. 23, 2017 Research and Markets ... - Forecast to 2021" report to their offering. ... The interventional radiology products ... USD 6.35 Billion in 2016, at a CAGR of 4.8%. This ... The major factors driving the growth of this market are ...
(Date:1/23/2017)... , Jan. 23, 2017  Delcath Systems, Inc. ... focused on the treatment of primary and metastatic liver ... Ph.D., MSN, CRNP, President and Chief Executive Officer of ... - Noble Capital Markets, Thirteenth Annual Investor Conference at ... Boca Raton, Florida , on Tuesday, January 31, ...
(Date:1/23/2017)... , January 23, 2017 ... (r enal) y el riesgo ... de a pabetalone    Resverlogix Corp. ... resultados preliminares de un ensayo en fase 1 con ... de riñón (renal) severa. Los datos demostraron unos resultados ...
Breaking Medicine Technology: